STOCK TITAN
  1. Home
  2. Sec-filings
  3. EHC
  4. [Form 4] Encompass Health Corp Insider Trading Activity

Encompass Health (EHC) director Terrance Williams receives 1,634-share equity grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Williams Terrance reported acquisition or exercise transactions in this Form 4 filing.

Encompass Health Corp director Terrance Williams received an equity grant of 1,634 shares of Encompass Health Common Stock. The shares were awarded at no cash cost as an annual grant of restricted stock units under the company’s 2025 Omnibus Performance Incentive Plan, bringing his direct holdings to 16,830 shares.

Positive

  • None.

Negative

  • None.
Insider Williams Terrance
Role null
Type Security Shares Price Value
Grant/Award Encompass Health Common Stock 1,634 $0.00 --
Holdings After Transaction: Encompass Health Common Stock — 16,830 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Share grant 1,634 shares Annual restricted stock unit award to director
Shares after transaction 16,830 shares Terrance Williams direct holdings following grant
Grant price per share $0.00 per share Reported transaction price for equity award
Transactions acquiring 1 transaction Grant/award acquisition reported in summary
Buy and sell count 0 buys, 0 sells No open-market purchases or sales in this filing
restricted stock units financial
"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2025 Omnibus Performance Incentive Plan financial
"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."
grant, award, or other acquisition regulatory
"transaction_code_description: Grant, award, or other acquisition"
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Williams Terrance
(Last)(First)(Middle)
9001 LIBERTY PARKWAY
(Street)
BIRMINGHAM ALABAMA 35242
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Encompass Health Common Stock05/07/2026A1,634(1)A$016,830D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.
/s/ Patrick Darby, attorney-in-fact for Terrance Williams05/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Encompass Health (EHC) director Terrance Williams report on this Form 4?

Terrance Williams reported receiving an equity grant of 1,634 shares of Encompass Health Common Stock. This award was made as part of his director compensation and increased his direct holdings to 16,830 shares after the transaction.

Was the Encompass Health (EHC) Form 4 transaction a stock purchase or sale?

The Form 4 shows an acquisition coded as a grant or award, not an open-market purchase or sale. Williams received 1,634 shares at a reported price of $0.00 per share as part of his annual equity compensation.

How many Encompass Health (EHC) shares does Terrance Williams hold after this grant?

After the reported grant, Terrance Williams directly holds 16,830 shares of Encompass Health Common Stock. This reflects an increase of 1,634 shares from the equity award disclosed in the Form 4 insider filing.

What is the source of the 1,634-share grant to Encompass Health (EHC) director Terrance Williams?

The 1,634-share grant comes from Encompass Health’s 2025 Omnibus Performance Incentive Plan. A footnote states it is an annual grant of restricted stock units awarded as part of the corporation’s long-term incentive compensation program.

Does the Encompass Health (EHC) Form 4 indicate any derivative or option exercises?

The filing does not report any derivative or option exercises. It shows a single non-derivative transaction: a grant of 1,634 Encompass Health Common Stock shares, with no derivative positions listed in the derivative summary section.